Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients

NCT01884038 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Liver Transplant

Interventions

DRUG: treprostinil sodium
DRUG: Placebo

Sponsor

United Therapeutics

Collaborators

[object Object]